Nine months Ended | ||
Sept. 30, | ||
2007 | 2006 | |
Cash flows from operating activities: | ||
Net income | $ 8,168 | $ 4,292 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 1,882 | 1,166 |
Stock-based compensation | 161 | 65 |
Restricted stock compensation | 102 | 112 |
Provision for doubtful accounts | 469 | 10 |
Changes in assets and liabilities: | ||
Accounts receivable | (2,154) | (1,741) |
Other assets | (238) | (722) |
Accounts payable and accrued expenses | (62) | (483) |
Accrued payroll and related benefits | (263) | (138) |
Deferred revenue | 622 | (284) |
Customer Deposits | 161 | -- |
Net cash provided by operating activities | 8,848 | 2,277 |
Cash flows from investing activities: | ||
Investment in Ebix Advantage | -- | (3,040) |
Investment in Finetre | (15) | -- |
Deferred Rent | (17) | 231 |
Capital expenditures | (502) | (370) |
Net cash used in investing activities | (534) | (3,179) |
Cash flows from financing activities: | ||
Payments on line of credit | (10,000) | -- |
Principal payments under debt obligations | (1,015) | (966) |
Capital leases | (2) | 13 |
Proceeds from the issuance of common stock, net issuance costs | 13,275 | 322 |
Proceeds from the exercise of the stock options | 237 | -- |
Repurchase of common stock | -- | (148) |
Net cash (used)/provided in financing activities | 2,495 | (779) |
Effect of foreign exchange rates on cash | 52 | 282 |
Net change in cash and cash equivalents | 10,861 | (1,399) |
Cash and cash equivalents at the beginning of the period | 5,013 | 6,733 |
Cash and cash equivalents at the end of the period | $ 15,874 | $ 5,334 |
Supplemental disclosures of cash flow information: | ||
Interest paid | $ 277 | $ -- |
Income taxes paid | $ 107 | $ 384 |